Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
360 OTC Hangover Relief is an over-the-counter (OTC) pharmaceutical preparation developed by Rockford-Montgomery Labs, a subsidiary of Three Sixty, Inc. It is formulated as an analgesic caplet specifically designed to alleviate the multi-symptom distress associated with hangovers, including headaches, fatigue, heartburn, upset stomach, and generalized body aches. The product was positioned as an FDA-approved OTC medication, with its inaugural manufacturing run completed in August 2007. While the specific active ingredients were not disclosed in the primary context, its classification as an analgesic and its indication for heartburn and fatigue suggest a combination of small molecule compounds such as pain relievers, antacids, or stimulants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 360 OTC Hangover Relief.